Literature DB >> 18054989

Physiological assembly and activity of human telomerase complexes.

Kathleen Collins1.   

Abstract

Telomerase is a specialized reverse transcriptase conserved throughout almost all eukaryotic life. It plays a fundamental role in genome maintenance, adding back the telomeric DNA repeats lost from chromosome ends due to incomplete replication or damage. The protein and RNA subunits of telomerase fold and function in a co-dependent manner to establish a high fidelity of telomeric repeat synthesis. Over the past two decades, studies of telomerase have uncovered previously unanticipated levels of complexity in its assembly, activity and regulation. This review describes the current understanding of telomerase in humans, with particular focus on telomerase biogenesis and regulation in its cellular context.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054989      PMCID: PMC2323683          DOI: 10.1016/j.mad.2007.10.008

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  79 in total

1.  Two inactive fragments of the integral RNA cooperate to assemble active telomerase with the human protein catalytic subunit (hTERT) in vitro.

Authors:  V M Tesmer; L P Ford; S E Holt; B C Frank; X Yi; D L Aisner; M Ouellette; J W Shay; W E Wright
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Functional requirement of p23 and Hsp90 in telomerase complexes.

Authors:  S E Holt; D L Aisner; J Baur; V M Tesmer; M Dy; M Ouellette; J B Trager; G B Morin; D O Toft; J W Shay; W E Wright; M A White
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

3.  PHAX and CRM1 are required sequentially to transport U3 snoRNA to nucleoli.

Authors:  Séverine Boulon; Céline Verheggen; Beata E Jady; Cyrille Girard; Christina Pescia; Conception Paul; Jason K Ospina; Tamas Kiss; A Gregory Matera; Rémy Bordonné; Edouard Bertrand
Journal:  Mol Cell       Date:  2004-12-03       Impact factor: 17.970

4.  A telomerase holoenzyme protein enhances telomerase RNA assembly with telomerase reverse transcriptase.

Authors:  Ramadevi Prathapam; Keren L Witkin; Catherine M O'Connor; Kathleen Collins
Journal:  Nat Struct Mol Biol       Date:  2005-02-06       Impact factor: 15.369

5.  Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT.

Authors:  Jun Hyun Kim; Sun-Mi Park; Mi Ran Kang; Sue-Young Oh; Tae H Lee; Mark T Muller; In Kwon Chung
Journal:  Genes Dev       Date:  2005-04-01       Impact factor: 11.361

6.  Telomerase is not an epidermal stem cell marker and is downregulated by calcium.

Authors:  J R Bickenbach; V Vormwald-Dogan; C Bachor; K Bleuel; G Schnapp; P Boukamp
Journal:  J Invest Dermatol       Date:  1998-12       Impact factor: 8.551

7.  Extension of life-span by introduction of telomerase into normal human cells.

Authors:  A G Bodnar; M Ouellette; M Frolkis; S E Holt; C P Chiu; G B Morin; C B Harley; J W Shay; S Lichtsteiner; W E Wright
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

8.  Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels.

Authors:  X Yi; V M Tesmer; I Savre-Train; J W Shay; W E Wright
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

9.  Characterization of interactions between PinX1 and human telomerase subunits hTERT and hTR.

Authors:  Soma S R Banik; Christopher M Counter
Journal:  J Biol Chem       Date:  2004-09-20       Impact factor: 5.157

10.  A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3' end.

Authors:  J R Mitchell; J Cheng; K Collins
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

View more
  55 in total

1.  Human telomerase domain interactions capture DNA for TEN domain-dependent processive elongation.

Authors:  Aaron R Robart; Kathleen Collins
Journal:  Mol Cell       Date:  2011-04-21       Impact factor: 17.970

2.  HMGB1 gene knockout in mouse embryonic fibroblasts results in reduced telomerase activity and telomere dysfunction.

Authors:  Eva Polanská; Zuzana Dobšáková; Martina Dvořáčková; Jiří Fajkus; Michal Štros
Journal:  Chromosoma       Date:  2012-04-28       Impact factor: 4.316

3.  RNA/DNA hybrid binding affinity determines telomerase template-translocation efficiency.

Authors:  Xiaodong Qi; Mingyi Xie; Andrew F Brown; Christopher J Bley; Joshua D Podlevsky; Julian J-L Chen
Journal:  EMBO J       Date:  2011-10-11       Impact factor: 11.598

Review 4.  Telomerase: an RNP enzyme synthesizes DNA.

Authors:  Elizabeth H Blackburn; Kathleen Collins
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-05-01       Impact factor: 10.005

5.  Structurally conserved five nucleotide bulge determines the overall topology of the core domain of human telomerase RNA.

Authors:  Qi Zhang; Nak-Kyoon Kim; Robert D Peterson; Zhonghua Wang; Juli Feigon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-21       Impact factor: 11.205

6.  The 5' guanosine tracts of human telomerase RNA are recognized by the G-quadruplex binding domain of the RNA helicase DHX36 and function to increase RNA accumulation.

Authors:  Alec N Sexton; Kathleen Collins
Journal:  Mol Cell Biol       Date:  2010-12-13       Impact factor: 4.272

Review 7.  DNA rearrangements directed by non-coding RNAs in ciliates.

Authors:  Kazufumi Mochizuki
Journal:  Wiley Interdiscip Rev RNA       Date:  2010 Nov-Dec       Impact factor: 9.957

8.  Harnessing fetal and adult genetic reprograming for therapy of heart disease.

Authors:  Shyam Sundar Nandi; Paras Kumar Mishra
Journal:  J Nat Sci       Date:  2015-04

Review 9.  Structured non-coding RNAs and the RNP Renaissance.

Authors:  J Robert Hogg; Kathleen Collins
Journal:  Curr Opin Chem Biol       Date:  2008-10-23       Impact factor: 8.822

10.  Solution structure and dynamics of the wild-type pseudoknot of human telomerase RNA.

Authors:  Nak-Kyoon Kim; Qi Zhang; Jing Zhou; Carla A Theimer; Robert D Peterson; Juli Feigon
Journal:  J Mol Biol       Date:  2008-10-11       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.